International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 114

Comparative Studies | Medicine Science | Volume 4 Issue 10, October 2015 | Pages: 1138 - 1142 | Kuwait


Fecal Calprotectin between Fact and Fiction: A Non-Invasive Rational Marker of Intestinal Inflammation Clinical and Histopathological Study

Yasser S. Sheta, Elsayed A. Elgohary, Abeer M. Hafez

Abstract: Background Bowel diseases are very common, most of them are functional not organic in nature but clinicians suffer a lot in differentiating between the two categories especially the management is completely different. The symptoms of functional bowel diseases including chronic lower abdominal pain/discomfort, distention and changes in bowel habits can be very similar to organic inflammatory bowel diseases like ulcerative colitis. In many cases the definitive diagnosis needs invasive procedures including lower colonoscopy and biopsy for histopathological documentation. Aim of the work To evaluate the clinical value of fecal calprotectin as a non invasive marker differentiating organic from functional bowel diseases in correlation with endoscopic and histopathological examinations. Subjects and methods The study included 40 subjects, selected to represent 2 groups group (I) included 20 patients with ulcerative colitis (UC) proved by colonoscopy and histopathology represent patients with organic inflammatory bowel diseases and further subdivided into sub-groups according to activity and site of involvement and group (II) included 20 patients who had symptoms suggestive of irritable bowel syndrome (IBS) and in whom colonoscopy was found to be normal served as control. All participants were subjected to thorough history taking, physical examination and routine laboratory investigations. Calprotectin in feces was measured using the enzyme-linked immunosorbent assay (ELISA). Results Fecal calprotectin concentration in the patients with UC was significantly higher than in patients with irritable bowel syndrome served as controls. (Mean values SD, 201.7 46.7 g/g vs, 22.3 10.1 g/g, P

Keywords: Fecal calprotectin, Ulcerative colitis, Enzyme-linked immunosorbent, irritable bowel syndrome, marker

How to Cite?: Yasser S. Sheta, Elsayed A. Elgohary, Abeer M. Hafez, "Fecal Calprotectin between Fact and Fiction: A Non-Invasive Rational Marker of Intestinal Inflammation Clinical and Histopathological Study", Volume 4 Issue 10, October 2015, International Journal of Science and Research (IJSR), Pages: 1138-1142, https://www.ijsr.net/getabstract.php?paperid=SUB158875, DOI: https://dx.doi.org/10.21275/SUB158875

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.